• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

Proportion of diabetic retinopathy (DR) among newly diagnosed type 2 diabetes mellitus patients attending tertiary care centre at Tripura medical college, Agartala: A cross sectional study

    Dr. Partha Chakma, Dr. Anarsh Debbarma, Dr.Koushik Chakma, Dr. Kaushik Tripura, Dr. Amar Kanti Chakma, Dr. Avik Chakraborty

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 8672-8677

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Objective: To estimate the proportion of diabetic retinopathy in newly diagnosed type 2 diabetes mellitus patients attending tertiary care centre at Tripura Medical College, Agartala.
Methods: The current study was a cross-sectional investigation conducted at the Tripura Medical College, Department of Ophthalmology. The study population included adults over the age of 18 with newly diagnosed type 2 diabetes mellitus (less than 6 months after diagnosis) between April 2021 and October 2022. Each patient had a thorough eye examination.
Results: 130 patients participated in the study, with a mean age of 43.2 ± 10.2 years and a 66.9% male patient population. Diabetic retinopathy was discovered in 11.5% (95% CI 14.7, 15.3) ofnewly diagnosed type 2 diabetes mellitus patients.
Conclusion: In this study, patient with newly discovered type 2 diabetes mellitus had a significant prevalence of retinopathy. This emphasises the significance of conducting a thorough ocular examination on all type 2 diabetes mellitus patients at the time of diagnosis.
Keywords:
    diabetes mellitus retinopathy Prevalence
  • PDF (198 K)
  • XML
(2022). Proportion of diabetic retinopathy (DR) among newly diagnosed type 2 diabetes mellitus patients attending tertiary care centre at Tripura medical college, Agartala: A cross sectional study. European Journal of Molecular & Clinical Medicine, 9(7), 8672-8677.
Dr. Partha Chakma, Dr. Anarsh Debbarma, Dr.Koushik Chakma, Dr. Kaushik Tripura, Dr. Amar Kanti Chakma, Dr. Avik Chakraborty. "Proportion of diabetic retinopathy (DR) among newly diagnosed type 2 diabetes mellitus patients attending tertiary care centre at Tripura medical college, Agartala: A cross sectional study". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 8672-8677.
(2022). 'Proportion of diabetic retinopathy (DR) among newly diagnosed type 2 diabetes mellitus patients attending tertiary care centre at Tripura medical college, Agartala: A cross sectional study', European Journal of Molecular & Clinical Medicine, 9(7), pp. 8672-8677.
Proportion of diabetic retinopathy (DR) among newly diagnosed type 2 diabetes mellitus patients attending tertiary care centre at Tripura medical college, Agartala: A cross sectional study. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 8672-8677.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 3
  • PDF Download: 11
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus